Medical Education

Understanding CKD-MBD: Pathophysiology, Burden and Clinical Consequences

Chronic kidney disease causes progressive loss of mineral homeostasis and a continuum of comorbidities and complications. Chronic kidney disease-mineral bone disorder (CKD-MBD) describes the broader clinical syndrome encompassing mineral homeostasis, vascular calcification and bone disorders1. This downloadable presentation describes how calcium and phosphate levels are normally maintained in the body…

Read more

Date of publication:
January 16, 2018

News & Views

Erythropoietic Response to Oral Iron in the FIND-CKD trial

The use of oral iron to correct iron deficiency and treat anaemia is associated with issues of compliance, gastrointestinal side-effects, non-response and variations in bioavailability between patients.1,2 However, as a simple and inexpensive option, it enjoys widespread use in non-dialysis dependent chronic kidney disease patients (ND-CKD). In an open-access paper,…

Read more

Date of publication:
January 10, 2018

Medical Education

Pathophysiology of Hyperkalaemia

Potassium is critical for many physiological functions. Although normal homeostatic mechanisms precisely maintain the serum potassium level within a narrow range, pathogenic disturbances can lead to hyperkalaemia, a relatively common clinical condition that can induce potentially fatal cardiac arrhythmias. Understanding the pathophysiology of hyperkalaemia is the focus of this e-learning…

Read more

Date of publication:
January 8, 2018

News & Views

ASN Kidney Week 2017: New Real-World Data on Phosphate Control

In this article, the COMPACT RENAL team provides a summary of key presentations from American Society of Nephrology Kidney Week 2017 relating to CKD-MBD, including real-world evidence on the phosphate binder sucroferric oxyhydroxide. KDIGO update An update to the KDIGO CKD-MBD guidelines was published earlier this year, in response to…

Read more

Date of publication:
December 11, 2017

News & Views

ASN Kidney Week 2017: The Impact of Hyperkalemia on RAASi Use and New Data on Novel Potassium Binders

At the American Society of Nephrology’s Kidney Week 2017 congress in New Orleans, results from several studies looking at the prevalence and impact of hyperkalemia were presented, alongside data for new therapies which may allow greater use of renin-angiotensin aldosterone system inhibition (RAASi) in patients with CKD and cardiac disease….

Read more

Date of publication:
December 11, 2017

News & Views

ASN Kidney Week 2017: Updates on Current Anaemia Management, With One Eye on Novel Therapies

The American Society of Nephrology (ASN) Kidney Week 2017 was held in New Orleans in early November 2017. Presentations related to iron deficiency and anaemia provided updates on both benefits and risks with current available therapies. Presenters also discussed treatments under development, particularly those that focus on activating the Hypoxia-Inducible…

Read more

Date of publication:
December 6, 2017

News & Views

Preview of ASN Kidney Week 2017: Iron Deficiency & Anaemia

This week New Orleans will host the ASN Kidney Week Congress. In preparation for this year’s meeting, the COMPACT RENAL team has summarised key sessions and posters relating to iron deficiency and anaemia. Note that hyperlinks to symposia will take you to the ASN Kidney Week website, where you will…

Read more

Date of publication:
November 2, 2017

News & Views

Preview of ASN Kidney Week 2017: Hyperkalemia

The American Society of Nephrology – Kidney Week 2017 (ASN 2017) congress takes place October 31st to November 5th 2017 in New Orleans. In this article, the COMPACT RENAL team has highlighted key sessions and posters relating to hyperkalemia. Note that hyperlinks to symposia will take you to the ASN…

Read more

Date of publication:
November 2, 2017

News & Views

Preview of ASN Kidney Week 2017: CKD-MBD

The ASN 2017 Kidney Week Congress starts this week in New Orleans. In this article, the COMPACT RENAL team has highlighted key sessions and posters relating to CKD-MBD. Note that hyperlinks to symposia will take you to the ASN Kidney Week website, where you will have the option to add…

Read more

Date of publication:
November 2, 2017

Medical Education

Nutrition Management and Hyperphosphataemia

Balancing phosphate levels and protein intake in dialysis dependent CKD patients is a significant challenge.[1] Impaired renal phosphate excretion and high protein dietary requirements frequently lead to hyperphosphatemia, which negatively impacts patients’ mineral bone health.[2] The growing elderly dialysis population is particularly challenging to manage due to its additional nutritional…

Read more

Date of publication:
October 12, 2017

Medical Education

What is the Right Vitamin D Target Level?

Vitamin D metabolism is central to the endocrine regulation of calcium and phosphorus homeostasis and its deficiency can result in serious morbidity including secondary hyperparathyroidism and fractures[1]. This downloadable presentation summarises the consequence of vitamin D insufficiency, discusses the vitamin D levels we should be targeting in our patients with…

Read more

Date of publication:
September 27, 2017

Presentation Resources

KDIGO 2017 CKD-MBD Update: Speaker’s Guide

The much anticipated KDIGO CKD-MBD Guidelines have recently been published (Full CKD-MBD Guidelines), along with an Executive Summary and summaries of the Evidence used in the update. The new guidelines are the result of significant effort by the KDIGO Guidelines Work Group and Evidence Review Team following the 2013 Controversies…

Read more

Date of publication:
September 12, 2017

Login

You are about to leave Compact-Renal.com

Clicking the "Continue" link below will take you to an external website. Compact Renal is not responsible for the contents of any external website. Compact Renal is providing these links to you as a convenience, and the inclusion of any links does not imply endorsement of the linked site by Compact Renal.

Do you wish to continue?

Continue Cancel